EULAR Updates ANCA-Associated Vasculitis Recommendations
A EULAR task force revised guidelines to reflect findings from randomized clinical trials that were published since the last update in 2016.
Diagnosis & Disease Information
Novel Potential Biomarker in ANCA-Associated Vasculitis Reported
Pentraxin-3 appears to reflect disease activity better than C-reactive protein.
An Elderly Man With Rapidly Progressive Glomerulonephritis
An 86-year-old man with history of hypertension (HTN), chronic obstructive pulmonary disease (COPD), and allergic rhinitis presented with one-week history of nausea, vomiting, diarrhea, and abdominal pain. Home medications included albuterol inhaler, carvedilol, hydralazine, and losartan. In the emergency department, he was found to be hypertensive with a blood pressure (BP) of 194/70 mm Hg…
Increased Prevalence of ANCA-Associated Vasculitis Reported
A population-based study of Swedish adults found that ANCA-associated vasculitis is more prevalent among men than women.
Daratumumab Successfully Treated a Case of Refractory ANCA-Associated Vasculitis
Use of the drug resulted in remission of severe pulmonary and cutaneous ANCA-associated vasculitis that resisted intensive conventional treatment.
Rituximab Confirmed as Standard of Care for Relapsing ANCA-Associated Vasculitis
Rituximab demonstrated superiority to azathioprine in a randomized trial.
Predictive Markers of CMV Viremia in ANCA-Associated Vasculitis Identified
Patients who experienced CMV viremia had significantly lower total protein, hemoglobin, and platelet and lymphocyte counts compared with those who did not.
Cyclophosphamide Plus Rituximab May Lower ANCA-Associated Vasculitis Relapse Risk
Recent study provides insight into treatment outcomes over a relatively long time period.
Avacopan’s Superiority for ANCA-Associated Vasculitis Persists Despite Low eGFR
Investigators conducted a subgroup analysis of patients with eGFR values of 20 mL/min/1.73 m2 or less in the phase 3 ADVOCATE trial.
Urinary T Cells May Help Diagnose ANCA-Associated Vasculitis
In a proof of concept study, urinary T cells outperformed soluble biomarkers in discriminating disease activity.
- Loading...
Loading...
Next post in End-Stage Renal Disease
Loading... 
Loading...